Vijaya Diagnostics Centre Limited stands as a pioneering force in the realm of diagnostic healthcare services across Southern India. Renowned for its unwavering commitment to excellence, the center provides an extensive array of services encompassing nuclear medicine, radiology, laboratory diagnostics, health check-ups, and a spectrum of medical services. As a frontrunner in the industry, Vijaya Diagnostics has consistently prioritized precision and patient-centric care.
In this article, we delve into a comprehensive exploration of the company, unravelling its contributions to advancing diagnostic medicare and shedding light on its integral role in shaping the healthcare landscape in Southern India.
About Vijaya Diagnostic Centre
Vijaya Diagnostics Centre Limited, the largest diagnostic chain in Southern India, epitomizes excellence in healthcare diagnostics. With an expansive network of 125 state-of-the-art centers across 20 Indian cities, the company boasts NABL-certified labs and a dedicated team of over 2200 professionals, including top pathologists, radiologists, and microbiologists. Their commitment to quality is underscored by routine training initiatives and surprise inspections to ensure international-grade diagnostic services.
As a testament to its success, Vijaya Diagnostics commands a market capitalization of ₹6,884 Cr., with a current stock price of ₹673 as of January 5th, 2024, solidifying its position as a leading force in the diagnostic healthcare sector.
Vijaya Diagnostic Centre Q2 FY2023-2024: Strong Financial Performance and Steady Growth
- Revenue Growth: Vijaya Diagnostic Centre Ltd achieved a notable 17.38% increase in revenue compared to the same period last year, reaching ₹145.61Cr in Q2 FY2023-2024.
- Quarterly Revenue Surge: The company demonstrated robust quarterly growth, with a remarkable 14.87% jump in revenue over the past three months.
- Net Profit Expansion: Vijaya Diagnostic Centre Ltd reported a substantial 42.82% surge in net profits, totaling ₹33.32Cr in Q2 FY2023-2024 compared to the corresponding period last year.
- Quarterly Net Profit Growth: The company exhibited a strong quarterly net profit growth, with a significant 27.18% increase in profits over the last three months.
- Profit Margin Enhancement: Vijaya Diagnostic Centre Ltd’s net profit margin increased by 21.67% compared to the same quarter last year, reaching an impressive 22.88% in Q2 FY2023-2024.
- Quarterly Profit Margin Boost: The company experienced a noteworthy 10.71% jump in net profit margins quarterly, showcasing sustained financial strength and operational efficiency.
Below are the trading platforms that you can use to purchase Vijaya Diagnostic Centre shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
| When | Maximum Price | Minimum Price |
| January 2024 | 726.84 | 632.03 |
| February 2024 | 741.67 | 644.93 |
| March 2024 | 756.81 | 658.10 |
| April 2024 | 734.77 | 638.93 |
| May 2024 | 723.91 | 629.49 |
| June 2024 | 749.97 | 652.15 |
| July 2024 | 742.47 | 645.63 |
| August 2024 | 772.17 | 671.45 |
| September 2024 | 803.05 | 698.31 |
| October 2024 | 787.31 | 684.62 |
| November 2024 | 810.93 | 705.15 |
| December 2024 | 831.20 | 722.78 |
Vijaya Diagnostic’s projected share prices for 2024 suggest a fluctuating trend, with January starting at a maximum of 726.84 and a minimum of 632.03. The stock is anticipated to peak in December at 831.20 and reach a low of 722.78.
The overall Stock P/E stands at 66.6, indicating a valuation based on earnings. Investors should consider these projections along with market dynamics for informed decision-making.
| When | Maximum Price | Minimum Price |
| January 2025 | 847.82 | 652.17 |
| February 2025 | 869.56 | 668.90 |
| March 2025 | 903.48 | 694.98 |
| April 2025 | 885.76 | 681.36 |
| May 2025 | 859.96 | 661.51 |
| June 2025 | 898.66 | 691.28 |
| July 2025 | 881.04 | 677.72 |
| August 2025 | 908.29 | 698.68 |
| September 2025 | 940.08 | 723.14 |
| October 2025 | 964.52 | 741.94 |
| November 2025 | 988.63 | 760.49 |
| December 2025 | 1,013.35 | 779.50 |
In 2025, Vijaya Diagnostic’s share price is expected to grow progressively, with a maximum of 847.82 and a minimum of 652.17 in January.
The trend continues upward, reaching its zenith in December at an estimated maximum of 1,013.35 and a minimum of 779.50.
| When | Maximum Price | Minimum Price |
| January 2026 | 1,043.75 | 802.89 |
| February 2026 | 1,070.51 | 823.47 |
| March 2026 | 1,112.26 | 855.59 |
| April 2026 | 1,090.45 | 838.81 |
| May 2026 | 1,058.69 | 814.38 |
| June 2026 | 1,106.33 | 851.03 |
| July 2026 | 1,084.64 | 834.34 |
| August 2026 | 1,118.19 | 860.14 |
| September 2026 | 1,157.32 | 890.25 |
| October 2026 | 1,187.41 | 913.40 |
| November 2026 | 1,217.10 | 936.23 |
| December 2026 | 1,247.53 | 959.64 |
Vijaya Diagnostic’s share price target for 2026 indicates a steady upward trajectory, with January starting at a maximum of 1,043.75 and a minimum of 802.89. The trend continues throughout the year, reaching its pinnacle in December at an estimated maximum of 1,247.53 and a minimum of 959.64.
| When | Maximum Price | Minimum Price |
| January 2027 | 1,272.48 | 978.83 |
| February 2027 | 1,305.11 | 1,003.93 |
| March 2027 | 1,356.00 | 1,043.08 |
| April 2027 | 1,329.42 | 1,022.63 |
| May 2027 | 1,290.70 | 992.84 |
| June 2027 | 1,348.78 | 1,037.52 |
| July 2027 | 1,322.33 | 1,017.18 |
| August 2027 | 1,363.23 | 1,048.64 |
| September 2027 | 1,410.94 | 1,085.34 |
| October 2027 | 1,447.62 | 1,113.56 |
| November 2027 | 1,483.81 | 1,141.40 |
| December 2027 | 1,520.91 | 1,169.93 |
| When | Maximum Price | Minimum Price |
| January 2028 | 1,551.33 | 1,193.33 |
| February 2028 | 1,591.11 | 1,223.93 |
| March 2028 | 1,653.16 | 1,271.66 |
| April 2028 | 1,620.74 | 1,246.73 |
| May 2028 | 1,573.54 | 1,210.41 |
| June 2028 | 1,644.35 | 1,264.88 |
| July 2028 | 1,612.11 | 1,240.08 |
| August 2028 | 1,661.96 | 1,278.43 |
| September 2028 | 1,720.13 | 1,323.18 |
| October 2028 | 1,764.86 | 1,357.58 |
| November 2028 | 1,808.98 | 1,391.52 |
| December 2028 | 1,854.20 | 1,426.31 |
| When | Maximum Price | Minimum Price |
| January 2029 | 1,891.29 | 1,454.84 |
| February 2029 | 1,939.78 | 1,492.14 |
| March 2029 | 2,015.43 | 1,550.33 |
| April 2029 | 1,975.91 | 1,519.93 |
| May 2029 | 1,918.36 | 1,475.66 |
| June 2029 | 2,004.69 | 1,542.07 |
| July 2029 | 1,965.38 | 1,511.83 |
| August 2029 | 2,026.17 | 1,558.59 |
| September 2029 | 2,097.08 | 1,613.14 |
| October 2029 | 2,151.61 | 1,655.08 |
| November 2029 | 2,205.40 | 1,696.46 |
| December 2029 | 2,260.53 | 1,738.87 |
| When | Maximum Price | Minimum Price |
| January 2030 | 2,305.74 | 1,773.65 |
| February 2030 | 2,364.86 | 1,819.13 |
| March 2030 | 2,457.09 | 1,890.07 |
| April 2030 | 2,408.92 | 1,853.01 |
| May 2030 | 2,338.75 | 1,799.04 |
| June 2030 | 2,444.00 | 1,880.00 |
| July 2030 | 2,396.08 | 1,843.13 |
| August 2030 | 2,470.18 | 1,900.14 |
| September 2030 | 2,556.64 | 1,966.64 |
| October 2030 | 2,623.11 | 2,017.78 |
| November 2030 | 2,688.69 | 2,068.22 |
| December 2030 | 2,755.90 | 2,119.93 |
Financial Condition Of Vijaya Diagnostic Centre: Last 5 Years
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 251 | 293 | 339 | 377 | 462 | 459 | 494 |
| Expenses | 171 | 184 | 206 | 211 | 259 | 277 | 295 |
| Operating Profit | 80 | 108 | 133 | 166 | 204 | 182 | 199 |
| OPM % | 32% | 37% | 39% | 44% | 44% | 40% | 40% |
| Other Income | 7 | 10 | 15 | 12 | 13 | 14 | 21 |
| Interest | 5 | 14 | 15 | 15 | 16 | 21 | 23 |
| Depreciation | 26 | 40 | 49 | 50 | 53 | 62 | 58 |
| Profit before tax | 55 | 65 | 83 | 112 | 147 | 114 | 139 |
| Tax % | 37% | 29% | 25% | 24% | 25% | 25% | |
| Net Profit | 35 | 46 | 63 | 85 | 111 | 85 | 104 |
| EPS in Rs | 77.44 | 101.29 | 138.00 | 18.64 | 10.76 | 8.29 | 10.12 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 9% | 12% |
Over the past five years, Vijaya Diagnostic Centre has exhibited a consistent and noteworthy financial performance. From March 2018 to the Trailing Twelve Months (TTM) in 2023, the company’s sales have experienced a substantial uptrend, growing from ₹251 crores to ₹494 crores.
Despite the increase in expenses from ₹171 crores to ₹295 crores, the company has effectively managed its financials, resulting in a resilient operating profit that rose from ₹80 crores to ₹199 crores. The Operating Profit Margin (OPM) has been consistently robust, reflecting efficient cost management and improved operational efficiency.
Notably, the company has maintained a prudent approach to its financial structure, with a disciplined dividend payout percentage. The Net Profit has demonstrated growth, reaching ₹104 crores in the TTM. Despite economic challenges, Vijaya Diagnostic Centre’s commitment to financial stability, operational excellence, and shareholder value is evident in its strategic financial decisions and consistent profitability.
FAQs
What is the current market capitalization of Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited currently boasts a market capitalization of a robust ₹6,884 Crores, underlining its substantial presence in the healthcare sector.
As of January 4th, 2024, the share price of Vijaya Diagnostic Centre Limited stands at an attractive ₹673, reflecting the market’s confidence in the company.
Looking ahead to 2025, the share price targets are encouraging, ranging from a minimum of ₹652.17 to an optimistic maximum of ₹1,013.35.
Visioning into the future, the anticipated share prices for 2030 showcase a promising range of ₹1,773.65 (minimum) to an impressive ₹2,755.90 (maximum).
What is the current Price-to-Earnings (P/E) ratio of Vijaya Diagnostic Centre Limited?
The current P/E ratio of 66.6 suggests an optimistic valuation relative to earnings, emphasizing the positive sentiment surrounding Vijaya Diagnostic Centre’s financial performance.
How has Vijaya Diagnostic Centre performed in Q2 FY2023-2024?
Q2 FY2023-2024 has been a standout period for Vijaya Diagnostic Centre, with a remarkable 17.38% YoY revenue growth and a substantial 42.82% increase in net profits, highlighting the company’s robust financial health.
What is the dividend payout percentage of Vijaya Diagnostic Centre for the last fiscal year?
In the last fiscal year, Vijaya Diagnostic Centre demonstrated its commitment to shareholders with a commendable 12% dividend payout percentage, aligning with its focus on creating value for investors.
How many diagnostic centres does Vijaya Diagnostic Centre operate, and in how many cities?
Operating a vast network, Vijaya Diagnostic Centre runs 125 state-of-the-art diagnostic centres spread across 20 Indian cities, providing widespread access to its high-quality healthcare services.
What distinguishes Vijaya Diagnostic Centre in terms of its healthcare services?
Vijaya Diagnostic Centre stands out for its comprehensive healthcare services, encompassing nuclear medicine, radiology, laboratory diagnostics, health check-ups, and medical services. The company’s unwavering commitment to precision and patient-centric care positions it as a leader in shaping the healthcare landscape.
Vijaya Diagnostics: A Pinnacle of Healthcare Excellence with Considerations for Investors
Vijaya Diagnostics Centre Limited stands as a beacon of excellence in Southern India’s diagnostic healthcare landscape, offering an extensive range of services from nuclear medicine to laboratory diagnostics. With a robust presence through 125 state-of-the-art centers across 20 cities, the company’s commitment to quality is underscored by NABL-certified labs and a skilled team of over 2200 professionals. Boasting a substantial market capitalization of ₹6,884 Crores, Vijaya Diagnostics demonstrated impressive financial performance in Q2 FY2023-2024, marked by a 17.38% YoY revenue surge and a remarkable 42.82% increase in net profits.
While the stock’s P/E ratio of 66.6 reflects positive market sentiment, investors should be mindful that the stock is trading at 10.4 times its book value, indicating a potential downside in terms of valuation. Careful consideration of these factors is crucial for informed investment decisions in this promising healthcare entity.
What did we learn?
- 1 About Vijaya Diagnostic Centre
- 2 Vijaya Diagnostic Centre Q2 FY2023-2024: Strong Financial Performance and Steady Growth
- 3 How To Purchase Vijaya Diagnostic Centre Shares?
- 4 Vijaya Diagnostic Share Price Target 2024 To 2030
- 4.1 Vijaya Diagnostic Share Price Target 2024
- 4.2 Vijaya Diagnostic Share Price Target 2025
- 4.3 Vijaya Diagnostic Share Price Target 2026
- 4.4 Vijaya Diagnostic Share Price Target 2027
- 4.5 Vijaya Diagnostic Share Price Target 2028
- 4.6 Vijaya Diagnostic Share Price Target 2029
- 4.7 Vijaya Diagnostic Share Price Target 2030
- 5 Financial Condition Of Vijaya Diagnostic Centre: Last 5 Years
- 6 FAQs
- 6.1 What is the current market capitalization of Vijaya Diagnostic Centre Limited?
- 6.2 What is the current share price of Vijaya Diagnostic Centre Limited?
- 6.3 What is the projected share price target for Vijaya Diagnostic Centre in 2025?
- 6.4 What is the projected share price target for Vijaya Diagnostic Centre in 2030?
- 6.5 What is the current Price-to-Earnings (P/E) ratio of Vijaya Diagnostic Centre Limited?
- 6.6 How has Vijaya Diagnostic Centre performed in Q2 FY2023-2024?
- 6.7 What is the dividend payout percentage of Vijaya Diagnostic Centre for the last fiscal year?
- 6.8 How many diagnostic centres does Vijaya Diagnostic Centre operate, and in how many cities?
- 6.9 What distinguishes Vijaya Diagnostic Centre in terms of its healthcare services?
- 7 Vijaya Diagnostics: A Pinnacle of Healthcare Excellence with Considerations for Investors
